|
Real-world treatment and quality of life (QOL) in locally advanced or metastatic urothelial carcinoma (la/mUC) in Saudi Arabia, Singapore, South Korea, Taiwan, and Turkey. |
| |
|
Employment - Astellas Pharma |
| |
|
Employment - Astellas Pharma |
Consulting or Advisory Role - Astellas Pharma |
Research Funding - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma |
Other Relationship - Astellas Pharma |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Regeneron |
| |
|
No Relationships to Disclose |
| |
|
Employment - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma |